PortfoliosLab logo

ASLAN Pharmaceuticals Limited (ASLN)

Equity · Currency in USD · Last updated Jun 30, 2022

Company Info

ISINUS04522R1014
CUSIP04522R101
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.50
Year Range$0.36 - $3.41
EMA (50)$0.52
EMA (200)$1.25
Average Volume$287.96K
Market Capitalization$35.01M

ASLNShare Price Chart


Chart placeholderClick Calculate to get results

ASLNPerformance

The chart shows the growth of $10,000 invested in ASLAN Pharmaceuticals Limited on May 7, 2018 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $895 for a total return of roughly -91.05%. All prices are adjusted for splits and dividends.


ASLN (ASLAN Pharmaceuticals Limited)
Benchmark (^GSPC)

ASLNReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M27.74%-8.16%
YTD-55.18%-19.88%
6M-55.58%-20.21%
1Y-85.53%-11.00%
5Y-44.13%9.08%
10Y-44.13%9.08%

ASLNMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

ASLNSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ASLAN Pharmaceuticals Limited Sharpe ratio is -1.09. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


ASLN (ASLAN Pharmaceuticals Limited)
Benchmark (^GSPC)

ASLNDividend History


ASLAN Pharmaceuticals Limited doesn't pay dividends

ASLNDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ASLN (ASLAN Pharmaceuticals Limited)
Benchmark (^GSPC)

ASLNWorst Drawdowns

The table below shows the maximum drawdowns of the ASLAN Pharmaceuticals Limited. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ASLAN Pharmaceuticals Limited is 96.48%, recorded on Jun 7, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.48%Jun 8, 20181007Jun 7, 2022
-10.31%May 31, 20181May 31, 20182Jun 4, 20183
-7.38%May 14, 201810May 25, 20181May 29, 201811
-2.32%May 7, 20181May 7, 20181May 8, 20182
-0.4%Jun 6, 20181Jun 6, 20181Jun 7, 20182
-0.32%May 9, 20181May 9, 20182May 11, 20183

ASLNVolatility Chart

Current ASLAN Pharmaceuticals Limited volatility is 57.30%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ASLN (ASLAN Pharmaceuticals Limited)
Benchmark (^GSPC)

Portfolios with ASLAN Pharmaceuticals Limited


Loading data...